Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Authors

Showing 6 results for author "Rithika Manjunatha Reddy".

Back to authors

Thumbnail for Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

CLL - 083

Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Clinical Predictors of Severe Cytokine Release Syndrome in CAR T-Cell Therapy for B-Cell Malignancies: A Systematic Review and Meta-Analysis

CT - 071

Clinical Predictors of Severe Cytokine Release Syndrome in CAR T-Cell Therapy for B-Cell Malignancies: A Systematic Review and Meta-Analysis

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Duration of Minimal Residual Disease Negativity Predicts Durable Disease Control in Multiple Myeloma: A Meta-Analysis of 8900 Patients

MM - 072

Duration of Minimal Residual Disease Negativity Predicts Durable Disease Control in Multiple Myeloma: A Meta-Analysis of 8900 Patients

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

$Thumbnail for Treatment Discontinuation and Dose Modifications Associated With Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 079

Treatment Discontinuation and Dose Modifications Associated With Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Is IgA Isotype an Independent Adverse Prognostic Factor in Multiple Myeloma? A Systematic Review and Meta-Analysis of Cytogenetic Risk, Survival, and Treatment Outcomes in the Modern Era

MM - 089

Is IgA Isotype an Independent Adverse Prognostic Factor in Multiple Myeloma? A Systematic Review and Meta-Analysis of Cytogenetic Risk, Survival, and Treatment Outcomes in the Modern Era

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Does Minimal Residual Disease Negativity Overcome High-Risk Cytogenetics After Autologous Stem Cell Transplantation in Multiple Myeloma?

MM - 130

Does Minimal Residual Disease Negativity Overcome High-Risk Cytogenetics After Autologous Stem Cell Transplantation in Multiple Myeloma?

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.